Stay updated on Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-18T13:50:35.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-11T09:31:58.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.9%
    Check dated 2025-08-04T07:36:59.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version of the HHS Vulnerability Disclosure, changing from v2.16.6 to v2.16.8.
    Difference
    0.2%
    Check dated 2025-07-28T02:13:03.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.1%
    Check dated 2025-07-20T23:08:47.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    A service alert has been added indicating planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours beginning at 9 PM EDT.
    Difference
    0.8%
    Check dated 2025-07-13T19:49:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.